Blueprint Medicines Corporation (BPMC)
Company Info
| ISIN | US09627Y1091 |
|---|---|
| CUSIP | 09627Y109 |
| Sector | Healthcare |
| Industry | Biotechnology |
Trading Data
| Previous Close | $57.38 |
|---|---|
| Year Range | $45.23 - $115.99 |
| EMA (50) | $57.37 |
| EMA (200) | $74.33 |
| Average Volume | $776.80K |
| Market Capitalization | $3.58B |
BPMCShare Price Chart
Click Calculate to get results
BPMCPerformance
The chart shows the growth of $10,000 invested in Blueprint Medicines Corporation on May 1, 2015 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $30,408 for a total return of roughly 204.08%. All prices are adjusted for splits and dividends.
BPMCReturns in periods
| Period | Return | Benchmark |
|---|---|---|
| 1M | 1.94% | -6.21% |
| YTD | -46.43% | -18.17% |
| 6M | -48.29% | -17.47% |
| 1Y | -36.82% | -8.89% |
| 5Y | 3.11% | 10.04% |
| 10Y | 16.83% | 9.15% |
BPMCMonthly Returns Heatmap
Click Calculate to get results
BPMCDividend History
Blueprint Medicines Corporation doesn't pay dividends
BPMCDrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
BPMCWorst Drawdowns
The table below shows the maximum drawdowns of the Blueprint Medicines Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Blueprint Medicines Corporation is 63.66%, recorded on Jun 13, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -63.66% | Dec 24, 2020 | 369 | Jun 13, 2022 | — | — | — |
| -62.86% | Jun 19, 2015 | 161 | Feb 8, 2016 | 198 | Nov 17, 2016 | 359 |
| -55.74% | Mar 16, 2018 | 195 | Dec 21, 2018 | 459 | Oct 19, 2020 | 654 |
| -32.79% | Nov 25, 2016 | 13 | Dec 13, 2016 | 59 | Mar 10, 2017 | 72 |
| -27.1% | May 2, 2017 | 20 | May 30, 2017 | 18 | Jun 23, 2017 | 38 |
| -24.32% | Jul 6, 2017 | 32 | Aug 18, 2017 | 18 | Sep 14, 2017 | 50 |
| -18.05% | Dec 12, 2017 | 6 | Dec 19, 2017 | 45 | Feb 26, 2018 | 51 |
| -13.61% | Nov 6, 2017 | 7 | Nov 14, 2017 | 11 | Nov 30, 2017 | 18 |
| -10.67% | Oct 30, 2020 | 14 | Nov 18, 2020 | 6 | Nov 27, 2020 | 20 |
| -10.62% | Dec 1, 2017 | 3 | Dec 5, 2017 | 4 | Dec 11, 2017 | 7 |
BPMCVolatility Chart
Current Blueprint Medicines Corporation volatility is 62.52%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.
Portfolios with Blueprint Medicines Corporation
Loading data...